A phase I study of the PI3K inhibitor buplarlisib (B) with concurrent chemoradiotherapy (CRT) in patients with high risk locally advanced squamous cell cancer of the head and neck (LASCCHN).

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. 6071-6071 ◽  
Author(s):  
Jochen H. Lorch ◽  
Roy B. Tishler ◽  
Nicole Grace Chau ◽  
Glenn J. Hanna ◽  
Guilherme Rabinowits ◽  
...  
Keyword(s):  
High Risk ◽  
Phase I ◽  
Head And Neck ◽  
Squamous Cell ◽  
Phase I Study ◽  
Concurrent Chemoradiotherapy ◽  
Squamous Cell Cancer ◽  
Cell Cancer ◽  
Locally Advanced ◽  
Pi3k Inhibitor

Multi-agent concurrent chemoradiotherapy for locally advanced head and neck squamous cell cancer in the elderly

Head & Neck ◽  
2011 ◽  
Vol 34 (8) ◽  
pp. 1147-1152 ◽  
Author(s):  
Stephanie A. Michal ◽  
David J. Adelstein ◽  
Lisa A. Rybicki ◽  
Cristina P. Rodriguez ◽  
Jerrold P. Saxton ◽  
...  
Keyword(s):  
Head And Neck ◽  
Squamous Cell ◽  
Concurrent Chemoradiotherapy ◽  
Squamous Cell Cancer ◽  
Cell Cancer ◽  
Locally Advanced ◽  
The Elderly ◽  
Advanced Head ◽  
Multi Agent ◽  
Neck Squamous Cell Cancer
Sign in / Sign up

Export Citation Format

Share Document